Shuttle Pharmaceuticals stock soars 373% following $10M IPO

Radiation therapy drug developer $Shuttle Pharmaceuticals(SHPH.US)$ saw its stock soar 373% following its $10M initial public offering on Wednesday.
Shares of Shuttle opened at $24.05, dipping to a low of $13.60 mid-morning before shooting up to a high of $84.70 amid multiple trading halts for volatility. The stock closed at $38.48, up 373% from its offering price.
For its IPO, Shuttle offered 1.23M units at $8.125 per unit. Each unit consisted of one share plus one warrant to buy one share for $0.01 per share.
Earlier this month, Shuttle said it was looking to offer 1.25M units at an assumed price of $8 per unit.
Based in Maryland, Shuttle has been working on treatments to help boost the effectiveness of radiation therapies for cancer.
$ARK Genomic Revolution ETF(ARKG.US)$ $iShares Core S&P 500 ETF(IVV.US)$ $Spdr S&P Health Care Equipment(XHE.US)$